209 related articles for article (PubMed ID: 28744809)
1. Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma.
Wang W; Yi M; Zhang R; Li J; Chen S; Cai J; Zeng Z; Li X; Xiong W; Wang L; Li G; Xiang B
Mol Cell Biochem; 2018 Jan; 438(1-2):47-57. PubMed ID: 28744809
[TBL] [Abstract][Full Text] [Related]
2. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Cao Q; Zhang J; Zhang T
Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
[TBL] [Abstract][Full Text] [Related]
3. Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma.
Zou G; Ren B; Liu Y; Fu Y; Chen P; Li X; Luo S; He J; Gao G; Zeng Z; Xiong W; Li G; Huang Y; Xu K; Zhang W
Cancer Sci; 2018 Nov; 109(11):3416-3427. PubMed ID: 30151927
[TBL] [Abstract][Full Text] [Related]
4. TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma.
Sang Y; Chen MY; Luo D; Zhang RH; Wang L; Li M; Luo R; Qian CN; Shao JY; Zeng YX; Kang T
Oncotarget; 2015 Oct; 6(30):29240-53. PubMed ID: 26335051
[TBL] [Abstract][Full Text] [Related]
5. Forkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma.
Ou-Yang L; Xiao SJ; Liu P; Yi SJ; Zhang XL; Ou-Yang S; Tan SK; Lei X
Mol Med Rep; 2015 Dec; 12(6):8003-9. PubMed ID: 26461269
[TBL] [Abstract][Full Text] [Related]
6. Oxidored-nitro domain containing protein 1 (NOR1) expression suppresses slug/vimentin but not snail in nasopharyngeal carcinoma: Inhibition of EMT in vitro and in vivo in mice.
Wang W; Li X; Zhang W; Li W; Yi M; Yang J; Zeng Z; Colvin Wanshura LE; McCarthy JB; Fan S; Zheng P; Chen S; Xiang B; Li G
Cancer Lett; 2014 Jun; 348(1-2):109-18. PubMed ID: 24657653
[TBL] [Abstract][Full Text] [Related]
7. High FMNL3 expression promotes nasopharyngeal carcinoma cell metastasis: role in TGF-β1-induced epithelia-to-mesenchymal transition.
Wu Y; Shen Z; Wang K; Ha Y; Lei H; Jia Y; Ding R; Wu D; Gan S; Li R; Luo B; Jiang H; Jie W
Sci Rep; 2017 Feb; 7():42507. PubMed ID: 28198387
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
Zhang T; Yin P; Zhang Z; Xu B; Che D; Dai Z; Dong C; Jiang P; Hong H; Yang Z; Zhou T; Shao J; Xu Z; Yang X; Gao G
Cell Death Dis; 2017 Jun; 8(6):e2838. PubMed ID: 28569772
[TBL] [Abstract][Full Text] [Related]
9. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
10. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
[TBL] [Abstract][Full Text] [Related]
11. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
13. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.
Wu Z; Li G; Wu L; Weng D; Li X; Yao K
BMC Cancer; 2009 Sep; 9():315. PubMed ID: 19732464
[TBL] [Abstract][Full Text] [Related]
14. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
15. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
16. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
Xie P; Yang JP; Cao Y; Peng LX; Zheng LS; Sun R; Meng DF; Wang MY; Mei Y; Qiang YY; Cao L; Xiang YQ; Luo DH; Yun JP; Huang BJ; Jia LJ; Qian CN
Cell Death Dis; 2017 Jun; 8(6):e2834. PubMed ID: 28569775
[TBL] [Abstract][Full Text] [Related]
17. Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis.
Li XJ; Ong CK; Cao Y; Xiang YQ; Shao JY; Ooi A; Peng LX; Lu WH; Zhang Z; Petillo D; Qin L; Bao YN; Zheng FJ; Chia CS; Iyer NG; Kang TB; Zeng YX; Soo KC; Trent JM; Teh BT; Qian CN
Cancer Res; 2011 Apr; 71(8):3162-72. PubMed ID: 21289131
[TBL] [Abstract][Full Text] [Related]
18. Stable knockdown of ZBTB7A promotes cell proliferation and progression in nasopharyngeal carcinoma.
Liu F; Tang F; Lan J; Jiao W; Si Y; Lu W; Mo M; Li B; Lu J; Wei J; Qin Y; Xiao R; Zhang B; Wang Y; Xiong W
Tumori; 2018; 104(1):37-42. PubMed ID: 29699474
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
20. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
